United States - English - NLM (National Library of Medicine)

allergan, inc. - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l) - fml forte ® suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. fml forte ® suspension is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. fml forte ® suspension is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.

United States - English - NLM (National Library of Medicine)

allergan, inc. - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l) - fml ® suspension is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. fml ® suspension is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye, and fungal diseases of ocular structures. fml ® suspension is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.

United States - English - NLM (National Library of Medicine)

allergan, inc. - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l) - fml ® ointment is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. fml ® ointment is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures. fml ® ointment is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.

Israel - English - Ministry of Health

abbvie biopharmaceuticals ltd, israel - fluorometholone - ophthalmic suspension - fluorometholone 0.1 %w/v - fluorometholone - fluorometholone - to treat eye inflammation.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - fluorometholone 0.1%{relative} (+5% overage) - eye drops, suspension - 0.1% w/v - active: fluorometholone 0.1%{relative} (+5% overage) excipient: benzalkonium chloride dibasic sodium phosphate disodium edetate dihydrate hydrochloric acid hypromellose monobasic sodium phosphate monohydrate polysorbate 80 polyvinyl alcohol purified water sodium chloride sodium hydroxide

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

senju pharmaceutical co.,ltd. - fluorometholone - white ophthalmic suspension when shaken, (volume)5ml

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

wakamoto pharmaceutical co., ltd - fluorometholone - white or milky white ophthalmic suspension, (cap) pale pink

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

wakamoto pharmaceutical co., ltd - fluorometholone - white or milky white ophthalmic suspension, (cap) deep pink

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

rohto nitten co., ltd. - fluorometholone - white ophthalmic suspension when shaken, (cap) light gray, (bottle) white translucent, (accompanying bag) clear

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

nitto medic co., ltd. - fluorometholone - slightly viscous and white sterile ophthalmic suspention, 5ml, (cap) baby pink, (label) clear label with baby pink band, (bottle) clear